[A case report of port-site metastasis of pancreatic cancer after laparoscope assistted distal pancreatectomy].

Chikato Koga, Masahiro Tanemura, Hiroshi Wada, Shogo Kobayashi, Shigeru Marubashi, Hidetoshi Eguchi, Masaki Mori, Yuichiro Doki, Hiroaki Nagano

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Laparosopic port-site metastasis is rare, but a well recognized outcome following surgery in gastroenterological surgery for gastric cancer, colon cancer and gallbladder cancer with its etiology was not clearly understood. We report a port-site metastasis of pancreatic cancer diagnosed by position emission tomography( PET). A 49-year-old man was diagnosed as splenic tumor with pancreatic tail invasion due to malignant lymphoma, and received a laparoscope assisted distal pancreatectomy. Unsuspected pancreatic cancer was discovered with histological result of moderate differentiated invasive ductal adenocarcinoma of the pancreas infiltrating spleen. Systemic chemotherapy with 1,000 mg/m2 of gemcitabine (GEM) was performed for six months. Unfortunately, our patients relapsed one year after the surgery with multiple lesions in the peritoneum, abdominal wall, as well as a laparoscopic port-site metastasis. He was started on 100 mg/body of S-1 daily, subsequently, combined chemotherapy with GEM( 80 mg/m2) and S-1( 80 mg/body) was also performed. Furthermore, he underwent palliative radiation therapy( 40 Gy) to care the pain. Fortunately, a long-term survival of 3 years was elicited by these systemic treatments and radiography. Laparoscopic port-site metastases are associated with presence of advanced cancer. Therefore, we should carefully precede a laparoscopic resection against pancreatic cancer.

Original languageEnglish
Pages (from-to)2454-2456
Number of pages3
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume38
Issue number12
Publication statusPublished - Jan 1 2011
Externally publishedYes

Fingerprint

Laparoscopes
Pancreatectomy
gemcitabine
Pancreatic Neoplasms
Neoplasm Metastasis
Gallbladder Neoplasms
Colonic Neoplasms
Drug Therapy
Peritoneum
Abdominal Wall
Palliative Care
Radiography
Stomach Neoplasms
Pancreas
Lymphoma
Neoplasms
Adenocarcinoma
Radiotherapy
Spleen
Tomography

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Koga, C., Tanemura, M., Wada, H., Kobayashi, S., Marubashi, S., Eguchi, H., ... Nagano, H. (2011). [A case report of port-site metastasis of pancreatic cancer after laparoscope assistted distal pancreatectomy]. Gan to kagaku ryoho. Cancer & chemotherapy, 38(12), 2454-2456.

[A case report of port-site metastasis of pancreatic cancer after laparoscope assistted distal pancreatectomy]. / Koga, Chikato; Tanemura, Masahiro; Wada, Hiroshi; Kobayashi, Shogo; Marubashi, Shigeru; Eguchi, Hidetoshi; Mori, Masaki; Doki, Yuichiro; Nagano, Hiroaki.

In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 38, No. 12, 01.01.2011, p. 2454-2456.

Research output: Contribution to journalArticle

Koga, C, Tanemura, M, Wada, H, Kobayashi, S, Marubashi, S, Eguchi, H, Mori, M, Doki, Y & Nagano, H 2011, '[A case report of port-site metastasis of pancreatic cancer after laparoscope assistted distal pancreatectomy].', Gan to kagaku ryoho. Cancer & chemotherapy, vol. 38, no. 12, pp. 2454-2456.
Koga, Chikato ; Tanemura, Masahiro ; Wada, Hiroshi ; Kobayashi, Shogo ; Marubashi, Shigeru ; Eguchi, Hidetoshi ; Mori, Masaki ; Doki, Yuichiro ; Nagano, Hiroaki. / [A case report of port-site metastasis of pancreatic cancer after laparoscope assistted distal pancreatectomy]. In: Gan to kagaku ryoho. Cancer & chemotherapy. 2011 ; Vol. 38, No. 12. pp. 2454-2456.
@article{2a53e6c81be54b4caf3a5006b3da03eb,
title = "[A case report of port-site metastasis of pancreatic cancer after laparoscope assistted distal pancreatectomy].",
abstract = "Laparosopic port-site metastasis is rare, but a well recognized outcome following surgery in gastroenterological surgery for gastric cancer, colon cancer and gallbladder cancer with its etiology was not clearly understood. We report a port-site metastasis of pancreatic cancer diagnosed by position emission tomography( PET). A 49-year-old man was diagnosed as splenic tumor with pancreatic tail invasion due to malignant lymphoma, and received a laparoscope assisted distal pancreatectomy. Unsuspected pancreatic cancer was discovered with histological result of moderate differentiated invasive ductal adenocarcinoma of the pancreas infiltrating spleen. Systemic chemotherapy with 1,000 mg/m2 of gemcitabine (GEM) was performed for six months. Unfortunately, our patients relapsed one year after the surgery with multiple lesions in the peritoneum, abdominal wall, as well as a laparoscopic port-site metastasis. He was started on 100 mg/body of S-1 daily, subsequently, combined chemotherapy with GEM( 80 mg/m2) and S-1( 80 mg/body) was also performed. Furthermore, he underwent palliative radiation therapy( 40 Gy) to care the pain. Fortunately, a long-term survival of 3 years was elicited by these systemic treatments and radiography. Laparoscopic port-site metastases are associated with presence of advanced cancer. Therefore, we should carefully precede a laparoscopic resection against pancreatic cancer.",
author = "Chikato Koga and Masahiro Tanemura and Hiroshi Wada and Shogo Kobayashi and Shigeru Marubashi and Hidetoshi Eguchi and Masaki Mori and Yuichiro Doki and Hiroaki Nagano",
year = "2011",
month = "1",
day = "1",
language = "English",
volume = "38",
pages = "2454--2456",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "12",

}

TY - JOUR

T1 - [A case report of port-site metastasis of pancreatic cancer after laparoscope assistted distal pancreatectomy].

AU - Koga, Chikato

AU - Tanemura, Masahiro

AU - Wada, Hiroshi

AU - Kobayashi, Shogo

AU - Marubashi, Shigeru

AU - Eguchi, Hidetoshi

AU - Mori, Masaki

AU - Doki, Yuichiro

AU - Nagano, Hiroaki

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Laparosopic port-site metastasis is rare, but a well recognized outcome following surgery in gastroenterological surgery for gastric cancer, colon cancer and gallbladder cancer with its etiology was not clearly understood. We report a port-site metastasis of pancreatic cancer diagnosed by position emission tomography( PET). A 49-year-old man was diagnosed as splenic tumor with pancreatic tail invasion due to malignant lymphoma, and received a laparoscope assisted distal pancreatectomy. Unsuspected pancreatic cancer was discovered with histological result of moderate differentiated invasive ductal adenocarcinoma of the pancreas infiltrating spleen. Systemic chemotherapy with 1,000 mg/m2 of gemcitabine (GEM) was performed for six months. Unfortunately, our patients relapsed one year after the surgery with multiple lesions in the peritoneum, abdominal wall, as well as a laparoscopic port-site metastasis. He was started on 100 mg/body of S-1 daily, subsequently, combined chemotherapy with GEM( 80 mg/m2) and S-1( 80 mg/body) was also performed. Furthermore, he underwent palliative radiation therapy( 40 Gy) to care the pain. Fortunately, a long-term survival of 3 years was elicited by these systemic treatments and radiography. Laparoscopic port-site metastases are associated with presence of advanced cancer. Therefore, we should carefully precede a laparoscopic resection against pancreatic cancer.

AB - Laparosopic port-site metastasis is rare, but a well recognized outcome following surgery in gastroenterological surgery for gastric cancer, colon cancer and gallbladder cancer with its etiology was not clearly understood. We report a port-site metastasis of pancreatic cancer diagnosed by position emission tomography( PET). A 49-year-old man was diagnosed as splenic tumor with pancreatic tail invasion due to malignant lymphoma, and received a laparoscope assisted distal pancreatectomy. Unsuspected pancreatic cancer was discovered with histological result of moderate differentiated invasive ductal adenocarcinoma of the pancreas infiltrating spleen. Systemic chemotherapy with 1,000 mg/m2 of gemcitabine (GEM) was performed for six months. Unfortunately, our patients relapsed one year after the surgery with multiple lesions in the peritoneum, abdominal wall, as well as a laparoscopic port-site metastasis. He was started on 100 mg/body of S-1 daily, subsequently, combined chemotherapy with GEM( 80 mg/m2) and S-1( 80 mg/body) was also performed. Furthermore, he underwent palliative radiation therapy( 40 Gy) to care the pain. Fortunately, a long-term survival of 3 years was elicited by these systemic treatments and radiography. Laparoscopic port-site metastases are associated with presence of advanced cancer. Therefore, we should carefully precede a laparoscopic resection against pancreatic cancer.

UR - http://www.scopus.com/inward/record.url?scp=84858802039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858802039&partnerID=8YFLogxK

M3 - Article

C2 - 22202411

AN - SCOPUS:84858802039

VL - 38

SP - 2454

EP - 2456

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 12

ER -